Lyon Joseph Douglas
Reporting owner on Forms 3, 4 and 5, CIK 1817838.
Lyon Joseph Douglas reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-10-05.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| CORCEPT THERAPEUTICS INC CIK 1088856 | officer (See Remarks) | 1 | 2026-10-05 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| CORCEPT THERAPEUTICS INC Common Stock | 2026-10-02 | M exercised | +3,357 | $13.56 | 9,040 | Form 4 |
| CORCEPT THERAPEUTICS INC Common Stock | 2026-10-02 | M exercised | +5,833 | $19.26 | 14,873 | Form 4 |
| CORCEPT THERAPEUTICS INC Common Stock | 2026-10-02 | S sold | -4,446 | $115.697 | 10,427 | Form 4 |
| CORCEPT THERAPEUTICS INC Common Stock | 2026-10-02 | S sold | -4,744 | $116.5407 | 5,683 | Form 4 |
| CORCEPT THERAPEUTICS INC Stock option (right to buy), derivative | 2026-10-02 | M exercised | -3,357 | $0 | 0 | Form 4 |
| CORCEPT THERAPEUTICS INC Stock option (right to buy), derivative | 2026-10-02 | M exercised | -5,833 | $0 | 44,167 | Form 4 |
| CORCEPT THERAPEUTICS INC Common Stock | 2026-10-01 | M exercised | +810 | $13.56 | 6,493 | Form 4 |
| CORCEPT THERAPEUTICS INC Common Stock | 2026-10-01 | S sold | -810 | $115.3985 | 5,683 | Form 4 |
| CORCEPT THERAPEUTICS INC Stock option (right to buy), derivative | 2026-10-01 | M exercised | -810 | $0 | 3,357 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001193125-26-414684 | CORCEPT THERAPEUTICS INC | 2026-10-05 |